Ohio Public Employees Retirement System (OPERS)
TERN

Ohio Public Employees Retirement System (OPERS)’s Terns Pharmaceuticals TERN Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,673
Closed -$15.7K – 2370
2025
Q1 		$15.7K Buy
+5,673
New +$23.2K ﹤0.01% 2219
2021
Q4 		– Sell
-400
Closed -$4K – 1994
2021
Q3 		$4K Buy
+400
New +$4.15K ﹤0.01% 1986

Other funds holding TERN

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s TERN Position: Q2 2025 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Terns Pharmaceuticals (TERN) in Q2 2025, closing a stake of 5,673 shares — an estimated $15.7K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in TERN in Q3 2021 and held it in 2 quarters. The position peaked at $15.7K in Q1 2025. 129 funds tracked by Wall St. Rank hold TERN as of Q2 2025.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Terns Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 5,673 Terns Pharmaceuticals shares in Q2 2025, an estimated $15.7K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Terns Pharmaceuticals in Q3 2021 and held it in 2 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Terns Pharmaceuticals position peaked at $15.7K in Q1 2025.
  • 129 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2025.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2025, filed 15 Jul 2025.